Advertisement

The Misuse and Abuse of Ophthalmic Preparations: a Scoping Review of Clinical Case Presentations and Extant Literature

  • Waed Al-Khalaileh
  • Mayyada Wazaify
  • Marie Claire Van Hout
Original Article
  • 93 Downloads

Abstract

The emergent trend of misuse and abuse of ophthalmic drugs is a public health concern. Common ophthalmic preparations contain anticholinergics, antihistamines, decongestants, anesthetics, and vasoconstrictive and topically applied nonsteroidal anti-inflammatory drugs. Misuse and abuse relates to their effect in causing euphoria, relaxation, hallucination, and reduction of depression symptoms. A scoping review of literature was conducted using Arskey and O’Malley (International Journal of Social Research Methodology 8(1):9–32, 2005) framework for mapping extant literature on the current knowledge of the issue. Four themes emerged: abuse of cycloplegics and mydriatics, misuse and abuse of topical ophthalmic anesthetics, misuse of topical ophthalmic vasoconstrictive and topically applied nonsteroidal anti-inflammatory drugs (NSAIDs), and public and pharmacist views on ophthalmic drug abuse/misuse. The review underscores the complex motives for misuse and abuse, availability of ophthalmic products, self-medication practices, presence of co-morbidities, and low public awareness which harms the important role of health professionals regarding suspected misuse of these common products.

Keywords

Ophthalmic preparations; abuse Misuse Community pharmacy 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. Adefule-Ositelu, A. O. (1989). Ocular drug abuse in Lagos, Nigeria. Acta Ophthalmologica, 67(4), 396–400.CrossRefPubMedGoogle Scholar
  2. Akkaya, C. (2008). Cyclopentolate abuse. Reactions, 1228, 15.Google Scholar
  3. Altinok, A. A., Balikoglu, M., Sen, E., & Serdar, K. (2010). Nonpreserved amniotic membrane transplantation for bilateral toxic keratopathy caused by topical anesthetic abuse: A case report. Journal of Medical Case Reports, 4(1), 262.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Anderson, S., Allen, P., Peckham, S., & Goodwin, N. (2008). Asking the right questions: Scoping studies in the commissioning of research on the organisation and delivery of health services. Health Research Policy and Systems, 6(1), 7.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Ansari, H., Garibaldi, D. C., & Jun, A. S. (2006). Anaesthetic abuse keratopathy as a manifestation of ocular Munchausen’s syndrome. Clinical & Experimental Ophthalmology, 34(1), 81–83.CrossRefGoogle Scholar
  6. Arskey, H., & O’Malley, L. (2005). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology, 8(1), 9–32.Google Scholar
  7. Balbani, A. P., Duarte, J. G., de Mello, J. F., D'Antonio, W. E., Camara, J., & Butugan, O. (2000). Toxicity of drugs used for treatment of rhinitis: A reminder to the otorhinolaryngologist. American Journal of Rhinology, 14(2), 77–82.CrossRefPubMedGoogle Scholar
  8. Bergin, M., Norman, I., Foley, M., Harris, R., Rapca, A., Rich, E., & Van Hout, M. C. (2015). Practice implications and recommendations for managing codeine misuse and dependence. Acta Pharmacologica, 65, 351–364.CrossRefGoogle Scholar
  9. Bersani, F. S., Corazza, O., Simonato, P., Mylokosta, A., Levari, E., Lovaste, R., & Schifano, F. (2013). Drops of madness? Recreational misuse of tropicamide collyrium; early warning alerts from Russia and Italy. General Hospital Psychiatry, 35(5), 571–573.CrossRefPubMedGoogle Scholar
  10. Bersani, F. S., Imperatori, C., Prilutskaya, M., Kuliev, R., & Corazza, O. (2015). Injecting eye-drops: A mini-review on the non-clinical use of tropicamide. Human Psychopharmacology: Clinical and Experimental, 30(4), 262–264.CrossRefGoogle Scholar
  11. Bhatia, S. S., Vidyashankar, C., Sharma, R. K., & Dubey, A. K. (2000). Systemic toxicity with cyclopentolate eye drops. Indian Pediatrics, 37(3), 329–331.PubMedGoogle Scholar
  12. Bozkurt, M., Karabulut, V., Evren, C., Seker, M., & Kan, H. (2015). Intravenous abuse of tropicamide in opioid use disorder: Presentation of 2 cases. Substance Abuse, 36(2), 170–173.CrossRefPubMedGoogle Scholar
  13. Burcu, A., Dogan, E., Yalniz-Akkaya, Z., & Ornek, F. (2013). Early amniotic membrane transplantation for toxic keratopathy secondary to topical proparacaine abuse: A report of seven cases. Cutaneous and Ocular Toxicology, 32(3), 241–247.CrossRefPubMedGoogle Scholar
  14. Casati, A., Sedefov, R., & Pfeiffer-Gerschel, T. (2012). Misuse of medicines in the European Union: A systematic review of the literature. European Addiction Research, 18(5), 228–245.CrossRefPubMedGoogle Scholar
  15. Chen, H. T., Chen, K. H., & Hsu, W. M. (2004). Toxic keratopathy associated with abuse of low-dose anesthetic: A case report. Cornea, 23(5), 527–529.CrossRefPubMedGoogle Scholar
  16. Chern, K., Meisler, D., Wilhelmus, K., Jones, B., Stern, G., & Lowder, C. (1996). Corneal anesthetic abuse and Candida keratitis. Opthalmology, 103(1), 37–40.CrossRefGoogle Scholar
  17. Cooper, R. J. (2013). Over-the-counter medicine abuse—A review of the literature. Journal of Substance Use, 18(2), 82–107.CrossRefPubMedGoogle Scholar
  18. Darcin, A. E., Dilbaz, N., Yilmaz, S., & Cetin, M. K. (2011). Cyclopentolate hydrochloride eye drops addiction: A case report. Journal of Addiction Medicine, 5(1), 84–85.CrossRefPubMedGoogle Scholar
  19. Daudt, H. M., van Mossel, C., & Scott, S. J. (2013). Enhancing the scoping study methodology: A large, inter-professional team’s experience with Arksey and O’Malley’s framework. BMC Medical Research Methodology, 13(1), 48.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Dayanır, V., Kırıkkaya, E. T., & Coşkun, F. (2013). Topical anesthetic abuse keratopathy and its clinical progression. Turkish Journal of Ophthalmology/Turk Oftalmoloji Dergisi, 43(4).Google Scholar
  21. Erdem, E., Undar, I. H., Esen, E., Yar, K., Yagmur, M., & Ersoz, R. (2013). Topical anesthetic eye drops abuse: Are we aware of the danger? Cutaneous and Ocular Toxicology, 32(3), 189–193.CrossRefPubMedGoogle Scholar
  22. Flach, A. J. (2001). Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Transactions of the American Ophthalmological Society, 99, 205.PubMedPubMedCentralGoogle Scholar
  23. Flach, A. J. (2006). Misuse and abuse of topically applied nonsteroidal anti-inflammatory drugs. Cornea, 25(10), 1265–1266.CrossRefPubMedGoogle Scholar
  24. Foley, M., Harris, R., Rich, E., Rapca, A., Bergin, M., Norman, I., & Van Hout, M. C. (2015). The availability of over-the-counter codeine medicines across the European Union. Public Health, 129(11), 1465–1470.CrossRefPubMedGoogle Scholar
  25. Frcophth, S. K., Fraco, G. L., Fraco, M. A., & Fraco, C. M. (1999). Ring keratitis from topical anaesthetic misuse. Clinical & Experimental Ophthalmology, 27(6), 440–442.Google Scholar
  26. Georgakopoulos, C. D., Vasilakis, P., Makri, O. E., Beredima, E., & Pharmakakis, N. (2011). Subconjunctival bevacizumab for corneal neovascularization secondary to topical anesthetic abuse. Cutaneous and Ocular Toxicology, 30(4), 320–322.CrossRefPubMedGoogle Scholar
  27. Goldich, Y., Zadok, D., Avni, I., & Hartstein, M. (2011). Topical anesthetic abuse keratitis secondary to floppy eyelid syndrome. Cornea, 30(1), 105–106.CrossRefPubMedGoogle Scholar
  28. Görgülü, Y., Ateş, I. Ç., Çınar, R. K., & Sönmez, M. B. (2015). Cyclopentolate use disorder: A case report of intranasal misuse. Bağımlılık Dergisi-Journal of Dependence, 16(1), 39–42.Google Scholar
  29. Hendershot, A. J., Colling, L., & Mauger, T. F. (2011). Corneal anesthetic abuse from the use of topical benzonatate (Tessalon Perle). Cornea, 30(12), 1518–1519.CrossRefPubMedGoogle Scholar
  30. Henkes, H. E., & Waubke, T. N. (1978). Keratittis from abuse of corneal anaesthetics. British Journal of Opthalmology, 62(1), 62–65.CrossRefGoogle Scholar
  31. Hidalgo Landa, A., Szabo, I., Le Brun, L., Owen, I., & Fletcher, G. (2011). Evidence based scoping reviews. The Electronic Journal Information Systems Evaluation, 14, 46–52.Google Scholar
  32. Hou, Y. C., Wang, I. J., & Hu, F. R. (2009). Ring keratitis associated with topical abuse of a dilute anesthetic after refractive surgery. Journal of the Formosan Medical Association, 108(12), 967–972.CrossRefPubMedGoogle Scholar
  33. Kadri, R., Hegde, S., Kudva, A. A., & Achar, A. (2010). Over the counter ophthalmic drug misuse, are we aware? Online Journal of Health and Allied Sciences, 9(2).Google Scholar
  34. Kadri, R., Hegde, S., Kudva, A. A., Achar, A., & Shenoy, S. P. (2011). Self-medication with over the counter ophthalmic preparations: Is it safe? International Journal of Biological and Medical Research, 2(2), 528–530.Google Scholar
  35. Katsimpris, J. M., Sarantoulakou, M., Kordelou, A., Petkou, D., & Petropoulos, I. K. (2007). Clinical findings in patients with topical anaesthetic abuse keratitis: A report of five cases. Klinische Monatsblätter für Augenheilkunde, 224(04), 303–308.CrossRefPubMedGoogle Scholar
  36. Kim, J. Y., Choi, Y. S., & Lee, J. H. (1997). Keratitis from corneal anesthetic abuse after photorefractive keratectomy. Journal of Cataract & Refractive Surgery, 23(3), 447–449.CrossRefGoogle Scholar
  37. Kintner, J., Grossniklaus, H., Lass, J., & Jacobs, G. (1990). Infectious crystalline keratopathy associated with topical anesthetic abuse. Cornea, 9(1), 77–80.CrossRefPubMedGoogle Scholar
  38. Kurna, S., Sengor, T., Suat, A., & Agirman, Y. (2012). Ring keratitis due to topical anaesthetic abuse in a contact lens wearer. Clinical and Experimental Optomotry, 95(4), 457–459.CrossRefGoogle Scholar
  39. Lessenger, J. E., & Feinberg, S. D. (2008). Abuse of prescription and over-the-counter medications. The Journal of the American Board of Family Medicine, 21(1), 45–54.CrossRefPubMedGoogle Scholar
  40. Levac, D., Colquhoun, H., & O’Brien, K. K. (2010). Scoping studies: Advancing the methodology. Implementation Science: IS, 5, 69.CrossRefPubMedGoogle Scholar
  41. Matti, A. I., & Saha, N. (2012). Topical ocular anaesthetic abuse in a contact lens wearer: A case of microbial keratitis. Clinical and Experimental Optometry, 95(6), 653–654.CrossRefPubMedGoogle Scholar
  42. Moreira, H., Kureski, M. L., Maira, O., & Fasano, A. P. (1991). Topical anesthetic abuse in Brazil. Ophthalmology, 98(9), 1322–1323.CrossRefPubMedGoogle Scholar
  43. Norman, I. J., Bergin, M., Parry, C. D., & Van Hout, M. C. (2016). Best practices and innovations for managing codeine misuse and dependence. Journal of Pharmacy & Pharmaceutical Sciences, 19(3), 367–381.CrossRefGoogle Scholar
  44. Ostler, H. B. (1975). Cycloplegics and mydriatics: Tolerance, habituation, and addiction to topical administration. Archives of Ophthalmology, 93(6), 432–433.CrossRefGoogle Scholar
  45. Otiashvili, D., Latypov, A., Kirtadze, I., Ibragimov, U., & Zule, W. (2016). Drug preparation, injection, and sharing practices in Tajikistan: A qualitative study in Kulob and Khorog. Substance Abuse Treatment, Prevention, and Policy, 11(1), 21.CrossRefPubMedPubMedCentralGoogle Scholar
  46. Parry, C., DeLuca, P., Cooper, R., & Van Hout, M. C. (2015). Should governments be more worried about the codeine misuse and dependence? Addiction, 110(10), 1690–1692.CrossRefPubMedGoogle Scholar
  47. Patel, M., & Fraunfelder, F. W. (2013). Toxicity of topical ophthalmic anesthetics. Expert Opinion on Drug Metabolism & Toxicology, 9(8), 983–988.CrossRefGoogle Scholar
  48. Pham, M. T., Rajić, A., Greig, J. D., Sargeant, J. M., Papadopoulos, A., & McEwen, S. A. (2014). A scoping review of scoping reviews: Advancing the approach and enhancing the consistency. Research Synthesis Methods, 5(4), 371–385.CrossRefPubMedPubMedCentralGoogle Scholar
  49. Ponté, C., Pi, C., Palmaro, A., Jouanjus, E., & Lapeyre-Mestre, M. (2017). Early signal of diverted use of tropicamide eye drops in France. British Journal of Clinical Pharmacology, 83(8), 1791–1800.CrossRefPubMedPubMedCentralGoogle Scholar
  50. Prilutskaya, M. V., & Kuliev, R. S. (2014). Clinico-dynamic features of withdrawal symptoms in patients with polydrug addiction of opioids and tropicamide. Voprosy Mentalnoy Medetsiny i Ecologii, 3(67), 3–4.Google Scholar
  51. Prilutskaya, M., & Kuliev, R. (2015). Analysis of clinical characteristic of nonmedical use of tropicamid by drug addicts in the republic of Kazakhstan. European Scientific Journal, ESJ, 11(3).Google Scholar
  52. Rajeev, A., Gupta, G., Adhikari, K. M., Yadav, A. K., & Sathyamoorthy, M. (2010). Neurotoxic effects of topical cyclopentolate. Medical Journal, Armed Forces India, 66(3), 288.CrossRefPubMedGoogle Scholar
  53. Rao, S. K., Wong, V. W., Cheng, A. C., Lam, P. T., & Lam, D. S. (2007). Topical anesthesia-induced keratopathy after laser-assisted subepithelial keratectomy. Journal of Cataract & Refractive Surgery, 33(8), 1482–1484.CrossRefGoogle Scholar
  54. Rapuano, C. J. (1990). Topical anesthetic abuse: A case report of bilateral corneal ring infiltrates. Journal of Ophthalmic Nursing & Technology, 9(3), 94–95.Google Scholar
  55. Risco, J. M., & Millar, L. C. (1992). Ultrastructural alterations in the endothelium in a patient with topical anesthetic abuse keratopathy. Ophthalmology, 99(4), 628–633.CrossRefPubMedGoogle Scholar
  56. Rosenwasser, G. O., Holland, S., Pflugfelder, S. C., Lugo, M., Heidemann, D. G., Culbertson, W. W., & Kattan, H. (1990). Topical anesthetic abuse. Ophthalmology, 97(8), 967–972.CrossRefPubMedGoogle Scholar
  57. Rumrill, P. D., Fitzgerald, S. M., & Merchant, W. R. (2010). Using scoping literature reviews as a means of understanding and interpreting existing literature. Work (Reading, Mass.), 35(3), 399–404.Google Scholar
  58. Sato, E. H., De Freitas, D., & Foster, C. S. (1992). Abuse of cyclopentolate hydrochloride(cyclogyl) drops. New England Journal of Medicine, 326(20), 1363–1364.PubMedGoogle Scholar
  59. Sharifi, A., Sharifi, H., Karamouzian, M., Mokhtari, M., Esmaeili, H. H., Nejad, A. S., & Rahmatian, M. (2013). Topical ocular anesthetic abuse among Iranian welders: Time for action. Middle East African Journal of Ophthalmology, 20(4), 336.CrossRefPubMedPubMedCentralGoogle Scholar
  60. Shei, A., Hirst, M., Kirson, N. Y., Enloe, C. J., Birnbaum, H. G., & Dunlop, W. C. (2015). Estimating the health care burden of prescription opioid abuse in five European countries. Clinico Economics and Outcomes Research: CEOR, 7, 477.CrossRefGoogle Scholar
  61. Shirzadeh, E., Shomoossi, N., & Abdolahzadeh, H. (2016). Topical anesthetic misuse in patients admitted to Sabzevar Eye Clinic in Iran. Acta Facultatis Medicae Naissensis, 33(4), 287–294.CrossRefGoogle Scholar
  62. Solomon, A., Siganos, C. S., & Frucht-Pery, J. (1996). Presumed herpetic keratitis and topical anesthetic abuse. Acta Ophthalmologica, 74(5), 518–519.CrossRefGoogle Scholar
  63. Soparkar, C. N., Wilhelmus, K. R., Koch, D. D., Wallace, G. W., & Jones, D. B. (1997). Acute and chronic conjunctivitis due to over-the-counter ophthalmic decongestants. Archives of Ophthalmology, 115(1), 34–38.CrossRefPubMedGoogle Scholar
  64. Spagnolo, P. A., Badiani, A., & Nencini, P. (2013). Polydrug abuse by intravenous use of heroin and tropicamide-containing eyedrops. Clinical Neuropharmacology, 36(3), 100–101.CrossRefPubMedGoogle Scholar
  65. Sugar, A. (1998). Topical anesthetic abuse after radial keratotomy. Journal of Cataract & Refractive Surgery, 24(11), 1535–1537.CrossRefGoogle Scholar
  66. Tappeiner, C., Sarra, G. M., & Abegg, M. (2009). Abuse of vasoconstrictive eyedrops mimicking an ocular pemphigoid. European Journal of Ophthalmology, 19(1), 129–132.CrossRefPubMedGoogle Scholar
  67. Tayanithi, P., & Aramwit, P. (2005). Self-medicated over the counter ophthalmic solutions in central Bangkok. Journal of the Medical Association of Thailand, 88, S330.PubMedGoogle Scholar
  68. Thomson Reuters. (2012). Endnote X6. New York: USW.Google Scholar
  69. Tok, O. Y., Tok, L., Atay, I. M., Argun, T. C., Demirci, N., & Gunes, A. (2015). Toxic keratopathy associated with abuse of topical anesthetics and amniotic membrane transplantation for treatment. International Journal of Ophthalmology, 8(5), 938.PubMedPubMedCentralGoogle Scholar
  70. Van Hout, M.C. (2014). “Doctor shopping and pharmacy hopping”: Practice innovations relating to codeine. Drugs and Alcohol Today, 14(4), 219–234.CrossRefGoogle Scholar
  71. Van Hout, M. C., & Norman, I. (2015). Over the counter codeine misuse: Recommendations for detection and reduction of risk in community pharmacies. International Journal of Drug Policy, 27, 17–22.CrossRefPubMedGoogle Scholar
  72. Varga, C. J. H., Rubinfeld, R. S., Wolf, T. C., Stutzman, C. R. D., Peele, M. K. A., Clifford, W. S., & Madigan, L. W. (1997). Topical anesthetic abuse ring keratitis: Report of four cases. Cornea, 16(4), 424–429.CrossRefPubMedGoogle Scholar
  73. Wazaify, M., Abood, E., Tahaineh, L., & Albsoul-Younes, A. (2016). Jordanian community pharmacists’ experience regarding prescription and nonprescription drug abuse and misuse in Jordan—An update. Journal of Substance Use, 1–6.Google Scholar
  74. Wazaify, M., Alali, M. B., Yousef, M. A., & Qammaz, S. (2017). Ophthalmic drops abuse in community pharmacy setting: A cross-sectional study from Jordan. Journal of Substance Use, 1–5.Google Scholar
  75. Wu, H., Hu, Y., Shi, X. R., Xu, F., Jiang, C. Y., Huang, R., & Jia, H. (2016). Keratopathy due to ophthalmic drug abuse with corneal melting and perforation presenting as Mooren-like ulcer: A case report. Experimental and Therapeutic Medicine, 12(1), 343–346.CrossRefPubMedPubMedCentralGoogle Scholar
  76. Yagci, A., Bozkurt, B., Egrilmez, S., Palamar, M., Ozturk, B. T., & Pekel, H. (2011). Topical anesthetic abuse keratopathy: A commonly overlooked health care problem. Cornea, 30(5), 571–575.CrossRefPubMedGoogle Scholar
  77. Yeniad, B., Canturk, S., Esin Ozdemir, F., Alparslan, N., & Akarcay, K. (2010). Toxic keratopathy due to abuse of topical anesthetic drugs. Cutaneous and Ocular Toxicology, 29(2), 105–109.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Waed Al-Khalaileh
    • 1
  • Mayyada Wazaify
    • 1
    • 2
  • Marie Claire Van Hout
    • 3
  1. 1.Department of Biopharmaceutics and Clinical Pharmacy, School of PharmacyThe University of Jordan (UJ)AmmanJordan
  2. 2.Department of Pharmacy, Faculty of Pharmacy and Medical SciencesAl-Ahliyya Amman UniversityAmmanJordan
  3. 3.Public Health Policy and Practice, Public Health InstituteLiverpool John Moore’s University (LJMU)LiverpoolUK

Personalised recommendations